据媒体报道，在全球激烈争夺的约39000个基因专利中，美国已获得其中的59%的23000个。也就是说，其他国家今后要开发基因药物，很可能要花巨资向美国购买基因专利。除美国外，其他发达国家也在加速基因专利的“圈地”。基因是一种有限的资源基因是生物制药产业的源头、生长点和 According to media reports, the United States has obtained 23,000 of these 59% of the approximately 39,000 genetic patents that have been fiercely contested throughout the world. In other words, other countries in the future to develop genetic drugs, it is likely to spend huge sums of money to the United States to buy genetic patents. In addition to the United States, other developed countries are also accelerating the “enclosure” of genetic patents. Genes are a Limited Resource Genes are the source, growth point and source of the biopharmaceutical industry